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Summary
T cells bearing y/b antigen receptors comprise a resident population ofintraepithelial lymphocytes
in organs such as skin, gut, and lungs, where they are strategically located to contribute to the
initial defense against infection . An important unsolved question about antigen-driven y/b T
cell responses regards the breadth of their T cell receptor (TCR) repertoire, since many specific
epithelial compartments in mice display limited diversity. We have examined the diversity of
TCR S gene expression among human y/b T cells from skin lesions induced by intradermal
challenge with Mycobacterium leprae . We show that the vast majority of'y/b cells from M. leprae
lesions use either V61-J61 or V62-J61 gene rearrangements and, within a given region of the
lesion, display limited junctional diversity. This contrasts markedly with the extensive diversity
of y/b T cells from peripheral blood of these same individuals, as well as skin from normal
donors . These results indicate that they/b response toM. leprae involves the selection of a limited
number ofclones from among a diverse repertoire, probably in response to specific mycobacterial
and/or host antigens .
One of the fundamental aspects of cellular immunologyis the selection and clonal expression of T cells bearing
specific receptors by antigens. While the selection of ci/(3
T cells has been studied in detail, little is known about the
selection ofy/b T cells by antigen . The genetic diversity of
the TCR provides a measure of the scope of the T cell reper-
toire. In contrast to the a/a TCR, the germline gene seg-
ment diversity for both the TCR y and S chains is small .
The further limitation of this diversity by the preferential
usage of only a few variable (V) genes or V gene pairs at
specific anatomical locations (1-3) suggests a particularly
narrow TCR repertoire, likely reflecting recognition of a
limited number of ligands . On the other hand, there is un-
precedented junctional diversity, particular in the b chains
of this receptor (4-6) . We reasoned that analysis of the TCR
y/b repertoire of a specific immune response would provide
clues about the set of antigens recognized : whether diverse
or limited, conventional, or superantigen-like. The presence
of antigen-reactive TCR -y/6-bearing cells in leprosy skin
lesions (7) provides a unique in vivo model to examine the
y/b receptor repertoire at the site of immunopathologic
reaction .
Much experimental evidence indicates that y/b T cells con-
tribute to the granuloma formation in response to mycobac-
terial infection (7) . First, TCR y/b cells comprise a strik-
ingly high percentage of the T cell population in infectious
disease lesions that contain recently formed granulomas. These
include lepromin skin tests (Mitsuda reactions), which are
experimental DTH reactions induced by intradermal injec-
tion ofMycobacterium lepme, reversal reactions in leprosy, which
represent a naturally occurring DTH response to M. leprae,
and localized American cutaneous leishmaniasis. Second, the
y/b T cells from these infectious lesions proliferate to mycobac-
terial antigens in vitro. Third, the y/b T cells from lesions
appear to release a lymphokine(s) that synergizes with gran-
ulocyte/macrophage (GM)-CSF to induce macrophage adhe-
sion, aggregation, and proliferation, cellular events that would
be necessary for the granulomatous response.
The present study was undertaken to determine the distri-
bution and TCR diversity of y/b T cell subpopulations in
lepromin skin tests . This was accomplished by immunopatho-
logic analysis according to VS chain expression and molec-
ular analysis of Vb, Jb, and junctional elements. The reper-
toire in these infectious lesions was compared with the
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Figure 1 A-F.
	
Immunohistochemical analysis of VS phenotypes in lesions and peripheral blood. Both V61 (A) and V62 (B) -bearing T cells were
present in the dermal granulomas of lepromin skin tests. In contrast, V61 cells Pwere present in the epidermis in greater numbers than V62 cells
(D), which were virtually absent . A more extensive view of the epidermis (E) shows V61 cells throughout . The percentages of V61- and V62-bearing
T cells (± SD) are shown in F.
peripheral blood of the same individual and the repertoire
in normal human skin .
Materials and Methods
ImmunoperoxidaseStaining ofBiopsies. Lepromin skin tests (3-wk
Mitsuda reactions) were studied from 14 tuberculoid leprosy pa-
tients (8) . All specimens were obtained with informed consent.
The patients were distributed among the different diagnostic groups
showing no segregation according to sex, race, or age. Skin biopsy
specimens were obtained by punch or scalpel technique at the time
of diagnosis, embedded in OCT medium (Ames Co., Elkhart, IN),
and snap frozen in liquid nitrogen . The tissues were stored at -70°C
until sectioning. Sections (3-5 P.m) were acetone fixed before un-
dergoing incubations with the mAbs for 45 min. mAbs included
the Cb-specific antibody antiTCR61 (9) (1:100, T-cell Sciences,
Boston, MA), the V61-J61-specific S antibody, 6TCS1 (1 :10, Tcell
Sciences), and the V62-specific antibody, BB3 (1:3,000 ; a generous
gift ofDr. L. Moretta, Istituto Nazionale per la Ricerca sul Cancro,
Genova, Italy) . The results obtained with 6TCS1 were corrobo-
rated with the V61-reactive antibody A13 (1:1,000 ; kindly provided
by Dr. S. Ferrini, Istituto Nazionale per la Ricerca sul Cancro,
Genova, Italy) . The primary antibody was visualized using the alka-
line phosphatase anti-alkaline phosphatase technique (Dako Corp.,
Carpinteria, CA). Slides were sequentially incubated with rabbit
anti-mouse antibody for 30 min, alkaline phosphatase mouse anti-
alkaline phosphatase immune complex for 30 min, and then devel-
oped with Vector Red substrate for 30 min (Vector Laboratories,
Burlingame, CA). Slides were washed in Tris buffer between incu-
bations . Endogenous alkaline phosphatase was blocked using 125
mM levamisole (Vector Laboratories). Slides were counterstained
with hematoxylin and then mounted in glycerine-gelatin . Some
slides were stained using theABC Elite system (Vector Laborato-
ries). The numbers ofVSpositive cells in the epidermis and dermis
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of an entire tissue section (-5 x 5 mm) were enumerated and
expressed as the percentage of total TCR61' cells in each micro-
au.atomic location . Peripheral blood was obtained from the same
individuals and analyzed by flow cytometry.
PCR Analysis . 20 5-P.m sections from each of five lepromin
skin tests were placed in 0.5 ml of4M guanidinium isothiocyanate
buffer. Additionally, 106 PBMC were obtained by Ficoll-Hypaque
density centrifugation . GenomicDNAwas isolatedby phenol/chlo-
roform extraction and ethanol precipitation with yields of 1-3 wg
of DNA. For each PCR reaction, -100 ng of DNA was used in
a 25-w1 reaction . By calculating the numbers of y/b cells/mm2 of
granuloma as detailed previously (10), and knowing the volume
oftissue utilized, we determined that each PCRreaction oflesions
contained DNA from -500 y/b T cells . Similar calculations for
peripheral blood indicated identical numbers of y/bTcells per each
reaction . Titration ofVBJS containing plasmid confirmed that the
sensitivity of our PCR amplification was on the order of 102 or
103 copies. PCR amplification mixtures contained 10 pmol of each
oligonucleotide primer, 2.5 U Taq polymerase (Promega Corp.,
Madison, WI), and 2.5 MM M9C12 in PCR buffer (Promega
Corp.) . Oligonucleotide primers were tested on a panel ofy/6 T
cell clones with known rearrangements. Sequences ofoligonucleo-
tide primers were selected to yield -300 by products (11) . 30 cycles
of PCR amplification were performed using the following condi-
tions: 1 min ofdenaturation at 94°C and 2 min of annealing/exten-
sion at 65°C . Amplified products were subjected to electropho-
resis on 1.5% agarose gels and visualized as single bands byethidium
bromide. Verification of product was accomplished by nucleotide
sequencing. Two skin biopsy specimens were obtained from normal
donors after informed consent. DNA was extracted from the en-
tire 4-mm punch biopsy and 100 ng used for PCR amplification
followed by sequencing of the V-J junctions.
Nucleotide Sequence Analysis of TLCR S VJJunctions. To facili-
tate cloning into sequencing vector, oligonucleotide primers for
PCR amplification were designed to contain a Sall or EcoRl re-
striction site in VS andJb primers, respectively. Amplified product
was digested with both restriction enzymes and gel purified. Purified
products were ligated into pUC18 vector and used to transform
DH5a (BRL Laboratories, Gaithersburg, MD) and selected for am-
picillin resistance. Plasmid DNA from insert containing colonies
was sequenced (Sequenase 2.0 Kit ; U.S. Biochemicals, Cleveland,
OH) using the method of Sanger et al. (12) . Precautions taken to
avoid PCR contamination artifact included the use ofpositive dis-
placement pipettes, assembling ofPCR reactions in a laminar flow
hood in a separate room from plasmid preparations, and inclusion
of negative and well-characterized controls in the PCR reactions.
Results
Distinct Microanatomic Localization of Vb T Cell Popula-
tions . The microanatomic distribution of 'y/b T cell sub-
populations within lepromin skin tests was investigated by
immunohistologic staining of frozen sections with mAbs
directed against Vb-encoded determinants (Fig . 1) . Within
the dermal granulomas, Vbl- and V62-bearing cells accounted
for the majority of infiltrating y/b cells, with a V62/V61
ratio -2:1 compared to 9:1 in the peripheral blood of these
same individuals . Unexpectedly, in contrast to the predomi-
nance of V62-bearing cells in the peripheral blood and in the
dermis, TCR6 * cells infiltrating the epidermis primarily ex-
pressed the V61-encoded TCRs. V82+ cells were rarely de-
tected in the epidermal layer.
Preferential Usage ofJ61 by y/b T Cells in Lesional Skin.
	
To
further characterize the repertoire of the y/b T cells in re-
sponse to mycobacterial stimulation in vivo, we performed
PCR amplification oftissue-derived vs . peripheral blood-de-
rived DNA using paired V and joining (J) oligonucleotide
primers. PCR conditions were established such that each PCR
reaction included DNA derived from -500 y/b T cells. PCR
analysis confirmed that Vbl and Vb2 were used by y/b T
cells in these lesions, as amplified product was obtained from
all five lesions for V61-J61 and V62-J61 rearrangements (Fig .
2) . In contrast, V62-J63 rearrangements were detected in 1/5
lesions, but 5/5 blood samples (Figure 2) . These data sug-
gest a selective localization of the V62-J61 subpopulation of
VS2+ cells to lesions . PCR using other VS and Jb combi-
nations did not reveal additional gene rearrangements (data
not shown) .
Limited functional Diversity of y/6 TCRs in Leprosy Skin
Lesions. Thejunctional diversity of y/b T cells in lepromin
skin tests was determined by cloning and sequencing PCR
amplified products . We chose to focus on TCR b chain diver-
sity for two reasons : it encodes the greatest amount of diver-
sity in the y/b receptor ; and it is specific for y/b T cells since
the b locus is deleted during rearrangement of the TCR a
chain . By using DNA rather than mRNA, bias towards ac-
tivated lymphoblasts containing abundant mRNA is elimi-
nated as each y/b T cell contains only one copy of its func-
tionally rearranged b gene. Strikingly, in each of the three
lepromin skin tests subjected to nucleotide sequencing anal-
ysis, the majority ofVblJb1 and V62-J61junctional sequences
were found to be identical, but distinct for each patient (Fig .
3) . This was clearly different from peripheral blood of these
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Figure 2 . PCR analysis of S chain V-J gene segment usage in lesions
and peripheral blood . VJ junctions were PCR amplified from DNA ex-
tracted from five lepromin skin tests (lanes A-E) and the peripheral blood
of the same individuals. PCR-amplified product was detected in all five
skin lesions and blood for VblJbl (A) and VS2JSl (B) . In all five blood
samples, but only one of five skin lesions, V62-J63 rearrangements could
be amplified (C) . No rearrangements were detected for any other VBJb
pairs (data not shown) .
AB
D
V61-J61 JUNCTIONAL NUCLEOTIDE SEQUENCES FROM BIOPSY OF LEPROMIN SKIN TESTS
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V62-J61 JUNCTIONAL NUCLEOTIDE SEQUENCES FROM BIOPSY OF LEPRONIN SKIM TESTS
V62-J61 JUNCTIONAL NUCLEOTIDE SEQUENCES FROM PATIENT PEMC
V61-JSI JUNCTIONAL NUCLEOTIDE SEQUENCES FROM PATIENT PBMC
Figure 3 . Nucleotide sequence
analysis ofTCR6 VJjunctions of
skin test lesions and blood . Se-
quencing of PCR products was
performed to analyze the diversity
at the VJjunction . Limited diver-
sity was found in both the V61-
J61(A) andV62JSl (B) junctions
of y/6 T cells from lesions in
patients A, B, and D. In contrast,
there was marked genetic diversity
in both theV61-J61 (C) and V62-
J61(D)junctions from the blood
of the same individuals . Nonfunc-
tional sequences are marked with
an asterisk .
P/N D_61 P/N D62 P/N D63 P/N J61 FREQUENCY
germline GTGACACC GAAATAGT CCTTCCTAC ACTGGGGGATACG ACACCCATAA
PT A GTGACACC G ATAG G CCTT GCAAT ACCGATAA (1/13)
GTGAC CCGGCC CTGGGG CCCACAT ACACCGATAA (1/13)
GTGACAC CCGGCCCG ACTGGGG CCCACATCACT CGATAA (1/13) "
GTGACACC TGAC AAT GC TCCT CCT ACACCGATAA (1/13)
GTGACACC C TACT GAAGG CTT ACC ACACCGATAA (1/13)
GTGAC CT ACTGGGGGAT T ACACCGATAA (1/13)
GTGA ATCGCTT TGGGGG T ACACCGATAA (1/13)
GTGACACC GTG CTGGGG CC ACACCCATAA (1/13)-
GTGAC CCCTTA GAAATA CGCT ACACCGATAA (1/13)
GTGAC TCAA TGGGGGATACG CAGG CCGATAA (1/13)
GTGAC CC ACTGGGGGAC CCAG ACACCGATAA (1/13)
GTGAC CAG CTGGGGG TTACTGAGG ACACCGATAA 11/13)
GTGACACC CTTTCGAGGG TCC CAG ACACCCATAA (1/13)
PT B GTGAC CCCTGT ACTGGGGG TACGTGT ACACCGATAA (2/12)
GTGACACC GCAACCACC GGGGG T ACACCGATAA (1/12)
GTGAC C CCT CTCGGTTG TGGGG TC ACACCGATAA (1/121
GTGAC CTAG TGGGGGA CC ACACCGATAA (1/12)
ETGAC GCGT ACTGGGGG GGAAAG ACACCGATAA (1/12)+
GTGACACC G TCCTAC G TGGGGG CCCTC ACACCGATAA (1/12)
GTGACAC COG ATAG AAGCACAA GGGGGAT ACACCGATAA (1/12)
GTGACACC TT ACTGGGGG CACCGA T ACACCGATAA (1/12) "
GTGAC GGC CTGGGGG GTATAAAGCGTG ACACCGATAA (1/12)
GTGACA A ACTGGGGG GTGCCTTT ACACCGATAA (1/12) "
OTC TGAC GGGGG TTCAGGAGTTTTT AA (1/12) "
PT D GTGAC CCCCG TCC CT ACTGGGGG CTACCGGGCG CACCGATAA (1/9)"
GT CTGGTGCATGCCCTG TACT CCCAG CTAC TC ACACCGATAA (1/9)
GT CATCC ACTGGGGG GCCCGT ACACCGATAA (1/9)
GTGAC GGCGC ACTGGGGG CGAAGA ACACCGATAA (1/9)
GTGAC CCTTGCTCCGGGGC ACT ACTGGGGGAT GCCGT ACACCGATAA (1/91 .
GTGAC CCAC ACTGG AGGCGAGCCCCAG ACACCGATAA (1/9)
GTGACACC GTC GGGGA CA ACACCGATAA (1/9)
GTGAC CAGGTC CTGGGGGATACG CGGGGAC CCGATAA (1/91
GTGACACC ACT ACTGGGGGAT TCCTCGT ACACCGATAA (1/9) .
VVal P/N 26-1 P/N 62 P/N D6 P/N J61 FREQUENCY
germline CTCTTGGGGAC GAAATAGT CCTTCCTAC ACTGGGGGATACG ACACCGATAA
PT A CTCTTGGGG CC GGGATAC GAG ACACCGATAA (1/5)
CTCTTGGGGA TCA TGGGG ACT ACACCGATAA (1/5)
CTCTTGGGGA T PLAT CTGGGGG CCA ACACCGATAA (1/5)
CTCTTGGGGAC CTT ATGA GGGGAT T ACACCGATAA (1/5) "
CTCTTGGGGAC TGG CCTAC TGGGGG T ACACCGATAA (1/5) "
PT B CTCTTGGGGAC A TCCT T ACTGGGGG GT ACACCGATAA (1/7)
CTCTTGGGGAC GA TCCT TAGCC ACACCGATAA (1/7)*
CTCTTGGGGAC TCC ACTGGGGG CCGT ACACCGATAA (1/7)w
CTCTTGGGGAC CACG TGGGGG G ACACCGATAA (1/7)
CTCTTGGGGAC ACGCGC GGGGA GA ACACCGATAA (1/7)
CTCTTGGGGAC TGCG TCCT TGTG TGGGG CC ACACCGATAA (1/7)
CTCTTGGGGA TTGCGT TGGGGG TO ACACCGATAA (1/7)"
PT D CTCTTGGGGAC CCCGGTG TGGGGG CATCC ACCGATAA (1/6)
CTCTTGGGGAC TCGAGGG TTCC A CTGGG AT ACACCGATAA (1/6)
CTCTTGGGGAC GGGACGAGG ACTGGG ACACCGATAA (1/6) "
CTCTTGGGGAC AACCTGTCG TCCT GCT ACACCGATAA (1/6)
CTCTTGGGGAC G TGGGG C ACACCGATAA (1/6)
CTC AAT CT ACTG CCAGCTGC ACACCGATAA (1/6)
Val P/N D61 P/N "6 P/N Qf3 P/N JJ61 FREQUENCY
germline CTCTTGGGGAC GAAATAGT CCTTCCTAC ACTGGGGGATACG ACACCGATAA
PT A CTCTTGGGGAC AT CTA ACCCCGACA GGGAT TA ACCGATAA (5/8)-
CTCT C TCCTA AGGGTAG CTGGGG TTCCC ACACCGATAA 13/8)
PT B CTCTTGGGGA TGCG CTA TTTGA GGGGGATACG CGAAATA ACACCGATAA (9/9)
PT D CTCTTGG TGACCCC GAA GTGAC TCC AG ACACCGATAA (8/8)
P/N 261 P/N 62 P/N D63_ P/N J61 FREQUENCY
germline GTGACACC GAAATAGT CCTTCCTAC ACTGGGGGATACG ACACCGATAA
PT A GTGACACC TTGC ACTGGGGGA GACGGG ACACCGATAA (6/6)
PT B GTGA TCG ACTGGGGG GCCCGT ACACCGATAA (B/B)
PT D GTGACACC G TGGGGG GAACCTCGT ACACCGATAA (11/13)
GTGACA GACC CCTT GAC CTGGGGGA GACGGGGAGG AA (1/13)
GTGACAC CC "CTGGGG CCCACAT ACACCGATAA (1/13)
same individuals, which exhibited extensive diversity (Fig.
3) . The data indicate clonal selection by antigen with
oligoclonal expansion within the lesion. The occurrence of
identical sequences that are nonproductive in a given sample
is likely to represent the nonfunctional allele in the cell un-
dergoing clonal expansion .
To determine the extent of oligoclonal expansion through-
out the lesion, spatially separated regions ofone biopsy spec-
imen were studied . Within each region of the biopsy spec-
imen, there was limited diversity of the VJjunctions, although
the predominant sequence differed from site to site (Fig. 4) .
Given the limited diversity observed in these lesions, we ad-
dressed the possibility of a PCR artifact producing the sur-
prising results. Extensive precautions were undertaken to avoid
PCR contaminations as outlined in the Materials and Methods.
Simultaneous PCR and cloning was performed on lesions
and blood, so that finding of limited diversity in lesions was
accompanied by finding of expected diversity in blood. The
finding of different predominant sequences in separate areas
of the biopsy argues against sample to sample contamina-
tion. The finding of limited diversity was obtained by com-
plete workup of tissue samples by three separate investigators
in three separate laboratories . We are confident that the PCR
reaction was performed on DNA from -500 cells and not
on a single cell based upon: (a) calculation of the number
of y1b cells in the biopsy specimen ; (b) comparison of PCR
product to PCR titration ofknown amounts of plasmid DNA
containing 6 gene segments; (c) appearance ofseveral unique
sequences along with the predominant sequence in many of
the clonings of lesional skin ; and (d) derivation of the same
sequence by separate PCR reactions and cloning of the tissue
sample.
Extensive Diversity of y/b TCRs in Normal Human Skin.
The resident y/b population in normal human skin is small,
with few cells identified by immunohistologic techniques (13) .
V6-J6 JUNCTIONAL NUCLEOTIDE SEQUENCES FROM PATIENT B BIOPSY OF LEPROMIN SKIN TEST
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We wanted to determine whether the limited TCR diversity
among -y1b T cells from leprosy lesions reflected a limited
diversity within the resident y/b population in skin or rather
clonal expansion of specific TCRs in response to antigenic
selection . The y/b TCR repertoire analysis of normal skin
indicated the presence of V62-J61 rearrangements, with minor
V61Jb1 products and undetectable V62-J63 gene rearrange-
ments (Fig. 5) . This indicates that in diseased or normal skin,
there is selective localization of y/b T cells expressing the
J61 gene product . Lack ofb chain-bearing J63 rearrangements
in DNA derived from normal skin further supports our con-
clusion that the PCR products are derived from a resident
y/b population, not from T cells within blood vessel lumina.
In contrast to diseased skin, the analysis of TCRjunctional
sequences derived from normal skin indicates extensive diversity
equivalent to peripheral blood (Fig. 5) .
Conserved Motif in Predicted Amino Acid Sequences of V,62-
J61 Junctions. The predicted amino acid sequences of pre-
dominant lesional V62-J61 gene junctions indicated con-
servation of amino acids from site to site within a biopsy
and from patient to patient (Fig . 6) . The conserved motif
comprised the 5' end of the VJ junction : T .L/V.G.G/D,
beginning in the third amino acid position after the second
cysteine of V62. This motif results primarily from the con-
tribution of V62, P, and D63 gene segments. A similar motif
is seen in the peripheral blood of these individuals, but only
in those clones that solely use the D63 gene segment (Fig.
6) . This motif was rarely observed in normal skin (Fig . 6) .
In addition, the length of the VJjunction was relatively con-
served in the lesional sequences, as compared to the periph-
eral blood .
To ascertain whether the conserved motif we observed in
the V62-J61 junctions of leprosy lesions was present in other
granulomatous diseases, we translated the V62-J61 nucleo-
tide sequences of y/6 T cells from the lungs of patients with
Clonal Selection of y/b T Cells in Response to a Human Pathogen
Figure 4.
	
Microheterogeneity
ofy/8 T cell receptors in lesions.
Within different regions of a bi-
opsy specimen, distinct clonal
junctional nucleotide sequences
were identified . Nonfunctional
sequences are marked with an
asterisk . Sequences marked by
a pound sign were obtained by
three separate PCR reactions and
cloning .
Vb2 P/N D61 P/N Db2 P/N D63 P/N J61 FREQUENCY
'germline GTGACACC GAAATAGT CCTTCCTAC ACTGGGGGATACG ACACCGATAA
AREA 1 GTGA TCG ACTGGGGG GCCCGT ACACCGATAA (8/e)
AREA 2 GTGAC GOO CTGGGGGATAC TA ACACCGATAA (10/17)
GTGACACC GTA GGGGG TCGGT ACACCGATAA (6/17)
GTGAC CCCC CTGGGG CCCACAT ACACCGATAA (1/17)-
GTGAC TCC ATT ACTGGGGGA GAACAGT ACACCGATAA (1/17)
AREA 4 GTGACACC GT CTGG A ACACCGATAA (15/30) f
GTGACACC A TGGGGGA CCCACGG GATAA (8/30)
GTGACACC GTGAC ACTGGGGG GTACGCTGAG CGATAA (1/30)
GTGACACC OTC CCTA CTGGGGG GGCCCT CACCGATAA (1/30)
GTGA TCC C CTGGGGG GGAGGG ACCGATAA (1/30)'
GTGAC GG ACTGGG CACCGATAA (1/30)
GTGACACC TGTA GGGGG G ACACCGATAA (1/30)
GTCACA TO CCTT G GGGGGATACG G ACACCOATAA (1/30)
GTGAC CG CCT GGGGG GCG ACACCGATAA (1/30)
Vdl-J61
V61 P/N D61 P/N Db2 P/N D63 P/N J61 FREQUENCY
germline CTCTTGGGGAC GAAATAGT CCTTCCTAC ACTGGGGGATACG ACACCGATAA
AREA 1 CTCTTGGGGA TGCG CIA TTTGA GGGGGATACG CGAAATA ACACCGATAA (9/9)
AREA 3 CTCTTGGG ACGGGGGTGA GGGGA CTCCAGG ACACCGATAA (12/12)
V62-J61
sarcoidosis (14) . This comparison revealed a relatively high
frequency of the T-L/V.G.G/D motifin V62-J61 junctional
sequences (data not shown) . This motifoccurred in the same
amino acid positions as in sequences from leprosy lesions,
but only when the D63 segment was the only D segment
used . The length of the VJjunction in the repeated sequences
of the sarcoidosis patients was conserved, at a length similar
to that observed in the leprosy lesion sequences. This was
in contrast to the variable length of the V62-J61 junction
sequences of normal blood y/6 T cells reported (14) .
Discussion
Distinct Microanatomic Patterns of V8 Populations in Leprosy
Lesions. Immunohistologic identification of VS T cell popu-
lations in leprosy lesions reveals distinct microanatomic pat-
terns for V61- and V62-bearing cells : the dermal infiltrate
containing both populations, but the epidermal y/6 T cells
preferentially expressing the V61 chain . The localization of
V61' cells to epidermis in these mycobacterial lesions sug-
gests either homing, retention, and/or in situ expansion of
V61 + cells during the immunopathogenic reaction . This lo-
calization of V61+ cells to an epithelial surface may be char-
acteristic of the inflammatory process . The gut epithelia of
689
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Figure 5 . PCR amplification
and 'PCR V-J junctional sequences
in normal skin . Analysis ofV6 and
J6 gene usage by PCR amplifica-
tion revealed product for both
V61-J61 and V62-J61 but not
other Vb-J5 combinations (A
shows the results for normal
donor F; donor G gave identical
results) . Nucleotide sequences of
Vb2J61 junctions revealed exten-
sive nucleotide diversity for spec-
imens from normal donors F and
G (B) . Nonfunctional sequences
are marked with an asterisk .
patients with Celiac disease, a gluten sensitive enteropathy,
was found to contain V61 + cells (15) .
The experimental evidence indicates that V61 and V62
populations may recognize distinct antigens and/or presen-
tation molecules. Some human V61 + cells appear to have
cytotoxic activity against allogeneic targets ; this cytotoxicity
is blocked by a mAb that recognizes a 43-kD protein termed
TCT1 (16) . Also, V61 + cells have been reported to recog-
nize CD1 molecules (17, 18) . Langerhans cells express CD1
molecules, can present antigen, and are increased in the
epidermis and dermis of these lesions (8) . Perhaps, the ex-
pression of the TCT1 molecule and/or CD1 molecules by
diseased epithelia results in the stimulation of the V61 popu-
lation . In contrast, human VS2+ cells expand in response
to M. tuberculosis antigens in vitro. The ability of these same
V62+ cells to proliferate to Daudi cell lines is blocked by a
polyclonal serum to a human HSP 58-kD protein (19) .
Limited Diversity ofy/S TCRs in Lesional Microenvironments
Suggests Clonal Selection by Antigen . The most striking data
presented here are the limited diversity of the VJjunctional
elements of y/6 T cells in leprosy lesions. The junctional
sequences of y/6 T cells from lesions were not found in the
respective individual's peripheral blood, indicating that the
lesional sequences do not represent an already existing clonal
LEPROSY SKIN BIOPSY SPECIMENS
PT A
	
C D T L H W G R R D K
PT B C D R L G G P Y T D K
C D G L G D T N T D K
C D T V G G R Y T D K
C D T W N T D K
C D T M G D P R T D K
PT D C D T V G G T S Y T D K
PBMC FROM LEPROSY PATIENTS
PT A C D T D T P C N T D K
C D S M G D T Q A D K
C D P L G D P D T D K
C D Q L G V T E D T D K
C D T Q C S S Y T D K
C E S L W G Y T D K
C D P L E I R Y T D K
C D T H W G I T P T D K
PT B C D P C T G G T C T D K
C D P S R L W H G T D K
C D L V G D H T D K
C D T V L R G G P H T D K
C D G L G G I K R D T D K
PT D C D P R P Y W G L P G A P K
C A G A C P V V P A T H T D K
C H R L G G P Y T D K
C D G A L G A K N T D K
C D P C S G A V L G D A V D K
C D P H W R R A P D T D K
C D T V G E N T D K
C D Q V L G D T R G P D K
NORMAL SKIN
NL F C D T D P W K T D K
C D H I V V T D K
C D S L L Y T D K
C D T S L L Y T D K
C E M G D W G I Y T D K
C D T P S L H D T D K
NL G C D T R V T G G C T D K
C D R L G G P Y T D K
Figure 6 . Predicted amino acid sequences based on V62J61 nucleotide
sequences. The predicted amino acid sequences for the predominant le-
sional V62-J61 junctions are shown . The conservation in amino acid se-
quences, the T-L/V-G-G/D motif beginning in the third amino acid po-
sition after the second cysteine of V62, is primarily encoded by the V62,
P, and the D63 gene segments. Although D63 gene segment usage is fre-
quent in the peripheral blood, the conserved motifdoes not appear in the
same location within the VJjunction with the high frequency of leprosy
lesional sequences. In addition, the junctional amino acid lengths of pe-
ripheral blood V62* cells are more variable, occasionally showing a greater
length than the lesion-derived sequences. The amino acid sequences of
normal skin show even greater heterogeneity.
expansion in the peripheral repertoire. It is noteworthy that
in each spatially separated region of the biopsy specimen, a
limited number ofjunctional nucleotide sequences were rep-
resented multiple times, although the predominant sequence
differed from site to site. Since there was conservation in the
predicted amino acid sequence in various areas of the biopsy
and among individuals, we hypothesize that they/6 T cell
expansion in lesions is selected by a limited set of antigens
within the tissue microenvironment . The limited micro-
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heterogeneity implies that a very small number of y/6 clones
initiate the oligoclonal expansion and that their progeny do
not disperse homogeneously throughout the lesion . Studies
of murine -y/b T cells indicate the positive selection of y/6
T cells in the periphery (20) . The study of leprosy lesions
indicates that the clonal selection by foreign antigen occurs
at the site ofinfection . Furthermore, y/b T cells in the lungs
and blood ofpatients with sarcoidosis (14) may similarly re-
sult from the oligoclonal expansion to antigen .
The nucleotide sequence analysis of lesional y/6 T cells
revealed that while V61J61 T cells utilize multiple Db seg-
ments at the VJ junction, the V62-J61 T cells use only the
D63 gene segment in 98% of the isolates. This is in contrast
to the 67% usage of D63 alone in sequences derived from
the blood of the same individuals, or the 33% usage in normal
skin . The differences in D6 usage suggest a fundamental dis-
tinction in the V61 and V62 populations in skin lesions . The
exclusive use of the D63 gene segment with minimal use of
N segments is a feature of y/6 T cells representing an early
fetal thymic wave (11) . Since V62-D63-J61 cells in leprosy
skin lesions were found to contain N segments, they are likely
derived from a later developmental stage when the levels of
terminal deoxynucleotide transferase are higher. The finding
of conserved amino acid residues and length of the predomi-
nant lesion-derived V62-J61junctions suggests that thejunc-
tional region, and specifically the D63-encoded sequence, par-
ticipates in antigen recognition (Fig. 4) . This is supported
by murine studies indicating that the junctional sequences
influence the specificity of the ylb TCR (21) . When com-
pared to the limited TCR diversity displayed by y/b T cells
from leprosy lesions, the normal skin data suggests that the
y/6 T cells in leprosy lesions represent clonal selection from
among a genetically diverse peripheral blood or resident skin
population . The reported diversity of VJ junctions in
mycobacterial-reactive murine y/6 T cells derived from
antigen-unselected neonatal thymus indicates that the breadth
of the antigen-reactive repertoire is large (22) .
Human vs. Murine Skin y/b T Cells. The normal murine
epidermis contains a dendritic cell population that is Thy-
1+ and bears y/6 TCRs. This resident population is of ex-
tremely limited genetic diversity, with virtually exclusive usage
of a single Vy gene and single V6 gene and no junctional
diversity (1) . Similar to the murine intraepidermal T cells,
we find the normal human TCR y/6 skin population to be
encoded by a restricted set of V and J genes (V62-J61) . In
response to infection, the epidermis is found to contain a
specific TCR 6 population (V61-J61), and all TCRs are of
limited genetic diversity.
Our findings indicate clear differences between human versus
murine skin y/6 T cells. The resident human skin popula-
tion, known to be significantly smaller than the murine resi-
dent population (13), displays extensive, rather than limited,
genetic diversity ofjunctional gene elements . Even in human
skin lesions of infectious etiology, the number of epidermal
y/6 T cells was relatively few as compared to the resident
murine population . However, limited genetic diversity occurs
in y/6 T cells responding to infection and appears to be due
to the oligoclonal expansion of specific TCR-bearing cells
from a diverse pool.
Implications.
	
y/ST cells appear to function as a first line
ofdefense against infectious pathogens (23) . This hypothesis
is based on the finding of large numbers of y/b T cells at
peripheral interfaces, including normal murine skin (24), gut
(25, 26), and lungs (3). y/S T cells derived from antigen-
unselected murine neonatal thymocytes (27) respond to
mycobacterial antigens in vitro. Furthermore, the initial im-
mune response to M. tuberculosis (28), Listeria monocytogenes
(29), and Trypanosoma cruzi (30) infection is characterized by
expansion of y/S T cells . In humans, y/b T cells accumulate
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